# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-054007
Filing Date
2024-06-20
Accepted
2024-06-20 07:30:08
Documents
5
Period of Report
2024-08-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | ea0207614-def14a_oramed.htm | DEF 14A | 323263
2 | GRAPHIC | image_001.jpg | GRAPHIC | 31114
3 | GRAPHIC | image_002.jpg | GRAPHIC | 28848
4 | GRAPHIC | image_003.jpg | GRAPHIC | 743935
5 | GRAPHIC | image_004.jpg | GRAPHIC | 594268
| Complete submission text file | 0001213900-24-054007.txt |  | 2250602

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35813 | Film No.: 241054068
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)